- Home
- FC vs ACIU Comparison
FC vs ACIU Comparison
Compare FC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FC
- ACIU
- Stock Information
- Founded
- FC 1983
- ACIU 2003
- Country
- FC United States
- ACIU Switzerland
- Employees
- FC N/A
- ACIU N/A
- Industry
- FC Other Consumer Services
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- FC Consumer Discretionary
- ACIU Health Care
- Exchange
- FC Nasdaq
- ACIU Nasdaq
- Market Cap
- FC 236.1M
- ACIU 213.3M
- IPO Year
- FC 1992
- ACIU 2016
- Fundamental
- Price
- FC $16.98
- ACIU $3.38
- Analyst Decision
- FC Strong Buy
- ACIU Strong Buy
- Analyst Count
- FC 2
- ACIU 2
- Target Price
- FC $27.00
- ACIU $10.00
- AVG Volume (30 Days)
- FC 88.6K
- ACIU 444.4K
- Earning Date
- FC 11-05-2025
- ACIU 10-31-2025
- Dividend Yield
- FC N/A
- ACIU N/A
- EPS Growth
- FC N/A
- ACIU N/A
- EPS
- FC 0.81
- ACIU N/A
- Revenue
- FC $279,943,000.00
- ACIU $36,362,036.00
- Revenue This Year
- FC N/A
- ACIU N/A
- Revenue Next Year
- FC $1.23
- ACIU $1,022.98
- P/E Ratio
- FC $20.89
- ACIU N/A
- Revenue Growth
- FC N/A
- ACIU 86.71
- 52 Week Low
- FC $16.60
- ACIU $1.43
- 52 Week High
- FC $44.16
- ACIU $4.00
- Technical
- Relative Strength Index (RSI)
- FC 38.33
- ACIU 55.26
- Support Level
- FC $16.60
- ACIU $3.23
- Resistance Level
- FC $19.52
- ACIU $4.00
- Average True Range (ATR)
- FC 0.77
- ACIU 0.38
- MACD
- FC -0.09
- ACIU 0.02
- Stochastic Oscillator
- FC 11.87
- ACIU 54.74
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.